Genshen Zhong
Changsha, 410022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Targeting ID2 to augment doxorubicin antitumor efficacy and enhance antibacterial defense without neutropenia.
Journal: International immunopharmacology
Published: June 27, 2026
ATPIF1 Deficiency Significantly Alleviates Citrobacter rodentium-Induced Colitis in Mice.
Journal: Journal of microbiology and biotechnology
Published: April 08, 2026
The critical role of Atpif1 in Her2-targeted CAR-T cell therapy for solid tumor via modulation of metabolism and mtDNA-STING signal pathway.
Journal: Frontiers in immunology
Published: October 28, 2025
The critical role of Id2 gene in mesenchymal stem cell therapy for colitis through regulating immune response and microbiota.
Journal: International immunopharmacology
Published: December 21, 2024
Enhanced glycolysis by ATPIF1 gene inactivation increased the anti-bacterial activities of neutrophils through induction of ROS and lactic acid.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 30, 2023
scRNA-seq reveals ATPIF1 activity in control of T cell antitumor activity.
Journal: Oncoimmunology
Published: August 26, 2022
Sirtuin 6 maintains epithelial STAT6 activity to support intestinal tuft cell development and type 2 immunity.
Journal: Nature communications
Published: October 18, 2021
Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils.
Journal: Frontiers in immunology
Published: August 19, 2021
Discovery of novel ID2 antagonists from pharmacophore-based virtual screening as potential therapeutics for glioma.
Journal: Bioorganic & medicinal chemistry
Published: July 21, 2021
Interplay between the Gut Microbiome and Metabolism in Ulcerative Colitis Mice Treated with the Dietary Ingredient Phloretin.
Journal: Journal of microbiology and biotechnology
Published: April 28, 2021
IF1 inactivation attenuates experimental colitis through downregulation of neutrophil infiltration in colon mucosa.
Journal: International immunopharmacology
Published: April 07, 2021
Last Updated: 09/26/2026